Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
National Cancer Institute
Start Date
July 20, 2021
End Date
June 30, 2026
Administered By
Medicine, Medical Oncology
Awarded By
National Cancer Institute
Start Date
July 20, 2021
End Date
June 30, 2026